Therefore, these collective data reported herein suggest that it is possible that the critical regulatory factors KRAS and SOX2, may significantly be influenced, not only by the 3D architectures of MM cell lines, but also by their physiological and pathological characteristics with several oncogenic signaling related factors as well as cell architecture supporting molecules. The gene discussed is KRAS; the disease is Miyoshi myopathy.